Literature DB >> 19656455

Clinical, biochemical and genetic characteristics of Variegate Porphyria in Italy.

E Di Pierro1, P Ventura, V Brancaleoni, V Moriondo, S Marchini, D Tavazzi, F Nascimbeni, M C Ferrari, E Rocchi, M D Cappellini.   

Abstract

Variegate Porphyria (VP) is an autosomal dominant disorder found worldwide but is rare in Italy. In this study we provide an overview of clinical, biochemical and genetic background of 33 Italian VP patients diagnosed in the last fifteen years. About 70% of patients had experienced clinical symptoms: 43.4% had photosensivity, 8.7% acute attacks and 47.8% both. Among the 33 patients, 14 different mutations were identified. Of these only 6 defects have been previously described in other countries and 8 are unique having been identified for the first time in Italy. Two of these, the c.851G>T and the c.1013C>G, were found in two and four unrelated families respectively. No mutation has been found in homozygosis and no significant correlation has been observed between specific clinical and biochemical manifestations and the type of mutation. In contrast, normal faecal protoporphyrin excretion was high predictive of silent phenotype. Normal urinary excretion of PBG and ALA, predicted absence of neurovisceral symptoms. This paper represents the first compilation of data on genotype-phenotype relation in Italian patients with VP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656455

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  6 in total

Review 1.  Porphyrias at a glance: diagnosis and treatment.

Authors:  Maria Domenica Cappellini; Valentina Brancaleoni; Giovanna Graziadei; Dario Tavazzi; Elena Di Pierro
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

2.  The porphyrias: pathophysiology.

Authors:  Antonello Pietrangelo
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

3.  X-chromosomal inactivation directly influences the phenotypic manifestation of X-linked protoporphyria.

Authors:  V Brancaleoni; M Balwani; F Granata; G Graziadei; P Missineo; V Fiorentino; S Fustinoni; M D Cappellini; H Naik; R J Desnick; E Di Pierro
Journal:  Clin Genet       Date:  2015-02-17       Impact factor: 4.438

4.  Quantitative structural insight into human variegate porphyria disease.

Authors:  Baifan Wang; Xin Wen; Xiaohong Qin; Zhifang Wang; Ying Tan; Yuequan Shen; Zhen Xi
Journal:  J Biol Chem       Date:  2013-03-06       Impact factor: 5.157

5.  Greater disease burden of variegate porphyria than hereditary coproporphyria: An Israeli nationwide study of neurocutaneous porphyrias.

Authors:  Ran Kaftory; Yonatan Edel; Igor Snast; Moshe Lapidoth; Rivka Mamet; Avishay Elis; Emmilia Hodak; Assi Levi
Journal:  Mol Genet Metab Rep       Date:  2021-01-13

6.  A case report on variegate porphyria after etonogestrel placement.

Authors:  Arianna Strome; Spencer D Hawkins; Yuan Yu Huang; Yolanda R Helfrich
Journal:  JAAD Case Rep       Date:  2022-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.